Funded Medical Equipment Manufacturing Startups in United States
Among the 11 most recent medical equipment manufacturing funding entries shown, Openwater’s $54M round (2024-08-22) and Presidio Medical’s $72M round (2023…
Among the 11 most recent medical equipment manufacturing funding entries shown, Openwater’s $54M round (2024-08-22) and Presidio Medical’s $72M round (2023-06-26) sit far above the rest of the disclosed amounts. The only other disclosed figures in the tens of millions are Galen Robotics at $15M (2022-11-01) and the remainder are mostly clustered at $3M or $2M (e.g., UNandUP $3M on 2023-07-17; Embolx $2M on 2022-11-01; Tetrous $2M on 2026-04-21). A second pattern is that several entries concentrate in late 2022: three undisclosed rounds appear on 2022-11-02 (Biocoat and Ka Imaging, both undisclosed; plus Neochord Inc at $3M on 2022-11-14), and two disclosed rounds show on 2022-11-01 (Embolx $2M and Galen Robotics $15M).
Stage/amount reporting is also mixed: five of the 11 rows use “Series Unknown” (Tetrous 2026-04-21 $2M; Provisio Medical 2025-05-01 $1M; UNandUP 2023-07-17 $3M; Neochord Inc 2022-11-14 $3M; Embolx 2022-11-01 $2M), while two rows are “undisclosed” amounts (CERV 2025-04-23; Biocoat and Ka Imaging both 2022-11-02). Geographically, California appears repeatedly (Tetrous, Provisio Medical, Openwater, and Presidio Medical), with additional placements in Missouri (CERV, UNandUP, and Neochord Inc) and one each in Minnesota, Pennsylvania, Iowa, and Maryland. The dated window runs from 2022-11-01 to 2026-04-21, with Tetrous the most recent.
Most recent rounds
11 shownRelated listings
Frequently asked
Which disclosed rounds look like the size outliers, and how separated are they from the rest of the disclosed amounts?
Presidio Medical’s $72M (2023-06-26) is the largest disclosed amount on the page, and it is well above the next-largest disclosed figures: Openwater at $54M (2024-08-22) and Galen Robotics at $15M (2022-11-01). Most remaining disclosed rounds fall at $3M or $2M (e.g., UNandUP $3M on 2023-07-17; Embolx $2M on 2022-11-01; Tetrous $2M on 2026-04-21).
Do the most recent entries cluster in time (e.g., last few months) or are they evenly spread across the shown period?
Within the displayed set, the dates span 2022-11-01 through 2026-04-21, but recent activity is front-loaded into the last two years. The most recent entries include Tetrous $2M on 2026-04-21 and Provisio Medical $1M on 2025-05-01, while the largest mid-window disclosure (Openwater $54M on 2024-08-22) sits between those and the dense late-2022 entries (multiple rounds in November 2022).
Which reporting-category pattern dominates: Series Unknown vs undisclosed amounts?
Five of the 11 rows list “Series Unknown” (Tetrous 2026-04-21 $2M; Provisio Medical 2025-05-01 $1M; UNandUP 2023-07-17 $3M; Neochord Inc 2022-11-14 $3M; Embolx 2022-11-01 $2M). Separately, two rows are “undisclosed” on the amount field (CERV 2025-04-23; Biocoat 2022-11-02), and one other entry is also “undisclosed” (Ka Imaging 2022-11-02).
Are any locations over-represented compared to the rest of the US cities listed?
California appears as a repeated hub across multiple companies: Tetrous (Sherman Oaks) on 2026-04-21, Provisio Medical (San Diego) on 2025-05-01, Openwater (San Francisco) on 2024-08-22, and Presidio Medical (South San Francisco) on 2023-06-26. Missouri also repeats with multiple entries (CERV 2025-04-23 and UNandUP 2023-07-17 in St Louis-area listings).
Which stage labels stand out, and do they align with the largest disclosed rounds?
Among explicitly labeled stages, Presidio Medical is the clearest upside case with Series C and a $72M round on 2023-06-26, while Galen Robotics is the next major labeled amount with Series A at $15M on 2022-11-01. Other labeled entries are smaller or not comparable by amount labels alone in this view (e.g., no other labeled rounds exceed the $15M level).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.